{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:57:16Z","timestamp":1793145436921,"version":"4.5.0"},"reference-count":42,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n There is a need for greater recognition of clinical psychopharmacology endpoints, including instances where specific psychotropic medications may become unnecessary, redundant, contradictory, or otherwise inappropriate and therefore merit deprescribing.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To address circumstances warranting psychotropic medication deprescribing.<\/jats:p>\n <\/jats:sec>\n \n Evidence Review<\/jats:title>\n The American Society of Clinical Psychopharmacology convened a panel of 45 international psychopharmacology experts who developed and completed a multiround Delphi survey and conducted a focused literature review between January and May of 2025, in order to identify areas of consensus or disagreement on key aspects of the deprescribing of psychotropic medications. These included collaborative risk-benefit assessments with patients; pharmacokinetic and pharmacodynamic factors; pharmacogenomics; distinguishing redundant or conflictual from complementary mechanisms of action; managing adverse effects; assuring medication adherence; drug tolerance or tachyphylaxis; medication misuse; and the psychological context and ramifications of deprescribing.<\/jats:p>\n <\/jats:sec>\n \n Findings<\/jats:title>\n Consensus was achieved on 44 of 50 final Delphi statements (88%). Panelists unanimously agreed that components of a pharmacotherapy regimen should undergo periodic review to ensure that treatments target relevant symptoms and have favorable risk-benefit ratios. Key points of consensus were that deprescribing: (1) should not occur without first assessing medication adherence; (2) merits consideration if less than partial therapeutic response is apparent, or if treatment goals have been reached and relapse prevention is not a long-term objective; (3) involves psychological ramifications that warrant attention; (4) should be followed by close clinical monitoring; and (5) risk-benefit decisions should ideally involve active patient participation within a shared decision-making model.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n Through this Consensus Statement, the Task Force identified circumstances in which the selective elimination of certain psychotropic medications may be clinically indicated. Empirical trials are needed to assess the implementation of deprescribing protocols and gauge their safe, effective, and acceptable outcomes.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.0043","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T16:30:30Z","timestamp":1772037030000},"page":"e260043","source":"Crossref","is-referenced-by-count":13,"title":["Recommendations for the Deprescribing of Psychotropic Medications"],"prefix":"10.1001","volume":"9","author":[{"given":"Joseph F.","family":"Goldberg","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly A.","family":"Swartz","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene P.","family":"Freeman","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Ammon-Pinizzotto Center for Women\u2019s Mental Health at Massachusetts General Hospital, Boston"},{"name":"Department of Psychiatry, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajnish","family":"Mago","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, SUNY Upstate Medical University, Syracuse, New York"},{"name":"Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Citrome","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Rosenblat","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada"},{"name":"Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada"},{"name":"Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Thase","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia"},{"name":"Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Tohen","sequence":"additional","affiliation":[{"name":"Department of Psychiatry & Behavioral Sciences, University of New Mexico, Albuquerque"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[{"name":"Bipolar and Depressive Disorders Unit, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"},{"name":"Institute of Neurosciences (UBNeuro), Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain"},{"name":"Biomedical Research Networking Centre on Mental Health (CIBERSAM), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain"},{"name":"Department of Medicine, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gin S.","family":"Malhi","sequence":"additional","affiliation":[{"name":"Academic Department of Psychiatry, Kolling Institute, Northern Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia"},{"name":"CADE Clinic and Mood-T, Royal North Shore Hospital, St Leonards, New South Wales, Australia"},{"name":"Department of Psychiatry, University of Oxford, Oxford, United Kingdom"},{"name":"Oxford Uehiro Centre for Practical Ethics, Faculty of Philosophy, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Sajatovic","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and of Neurology, Case Western Reserve University School of Medicine, Cleveland, Ohio"},{"name":"Neurological and Behavioral Outcomes Center, University Hospitals Cleveland Medical Center, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"Shelton","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neurobiology, University of Alabama Heersink School of Medicine, Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Macaluso","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neurobiology, University of Alabama Heersink School of Medicine, Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Berk","sequence":"additional","affiliation":[{"name":"Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Deakin University, Barwon Health, Geelong, Victoria, Australia"},{"name":"Mental Health, Drugs and Alcohol Service, Barwon Health, Geelong, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy H.","family":"Perlis","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Harvard Medical School, Boston, Massachusetts"},{"name":"Center for Quantitative Health, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Ostacher","sequence":"additional","affiliation":[{"name":"Department of Veterans Affairs, Washington, DC"},{"name":"School of Medicine, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arifulla","family":"Khan","sequence":"additional","affiliation":[{"name":"Northwest Clinical Research Center, Bellevue, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan V.","family":"Iosifescu","sequence":"additional","affiliation":[{"name":"Nathan Kline Institute, Orangeburg, New York"},{"name":"New York University Grossman School of Medicine, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Sanacora","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Yale University, Yale-New Haven Hospital, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Manuel","family":"Rubio","sequence":"additional","affiliation":[{"name":"The Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York"},{"name":"Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, Hempstead, New York"},{"name":"Feinstein Institutes for Medical Research, Institute of Behavioral Science, Manhasset, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Kane","sequence":"additional","affiliation":[{"name":"The Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York"},{"name":"Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, Hempstead, New York"},{"name":"Feinstein Institutes for Medical Research, Institute of Behavioral Science, Manhasset, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Goodman","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland"},{"name":"Department of Psychiatry, Norton College of Medicine at SUNY Upstate Medical University, Syracuse, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"Nierenberg","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Harvard Medical School, Boston, Massachusetts"},{"name":"Dauten Family Center for Bipolar Treatment Innovation, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph U.","family":"Correll","sequence":"additional","affiliation":[{"name":"The Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York"},{"name":"Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, Hempstead, New York"},{"name":"Department of Child and Adolescent Psychiatry, Charit\u00e9 Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Kupka","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Amsterdam University Medical Center, Amsterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegfried","family":"Kasper","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Clinical Division of General Psychiatry, Medical University of Vienna, Vienna, Austria"},{"name":"Center for Brain Research, Department of Molecular Neuroscience, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshi A.","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Kyoto University Office of Institutional Advancement and Communications, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Davis","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neurobiology, University of Alabama Heersink School of Medicine, Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott T.","family":"Aaronson","sequence":"additional","affiliation":[{"name":"Institute for Advanced Diagnostics and Treatment, Sheppard Pratt Health System, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Gitlin","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Geffen School of Medicine at UCLA, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish K.","family":"Jha","sequence":"additional","affiliation":[{"name":"Center for Depression Research and Clinical Care, Peter O\u2019Donnell Jr Brain Institute, Department of Psychiatry, UT Southwestern Medical Center, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence J.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy, University of North Texas System College of Pharmacy, Fort Worth"},{"name":"Department of Medical Education, Texas College of Osteopathic Medicine, University of North Texas Health Science Center, Fort Worth"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George I.","family":"Papakostas","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Psychiatry, Clinical Trials Network and Institute, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip B.","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Discipline of Psychiatry and Mental Health, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Gorwood","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, INSERM U1266, Institute of Psychiatry and Neurosciences of Paris (IPNP), Paris, France"},{"name":"GHU Paris Psychiatrie et Neurosciences (CMME, Sainte-Anne Hospital), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapnil","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York"},{"name":"Castle Point VA Medical Center, Wappingers Falls, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Frye","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan H.","family":"Young","sequence":"additional","affiliation":[{"name":"Centre for Affective Disorders (CfAD), Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Zohar","sequence":"additional","affiliation":[{"name":"Psychiatric Division, Chaim Sheba Medical Center, Tel Hashomer, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Steingard","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Vermont Larner College of Medicine, Burlington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Carlos A.","family":"Zarate","sequence":"additional","affiliation":[{"name":"Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita H.","family":"Clayton","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Neurobehavioral Sciences, University of Virginia School of Medicine, Charlottesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"For the American Society of Clinical Psychopharmacology Task Force on the Deprescribing of Psychotropic Medications","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"issue":"5","key":"zcs260001r1","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing inappropriate polypharmacy: the process of deprescribing.","volume":"175","author":"Scott","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"4","key":"zcs260001r2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.25ac15936","article-title":"What is meant by the term \u201cdeprescribing\u201d and does it belong in our lexicon?","volume":"86","author":"Goldberg","year":"2025","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"zcs260001r3","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/bcp.12386","article-title":"Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process.","volume":"78","author":"Reeve","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"zcs260001r4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0282988","article-title":"\u201cStabilise-reduce, stabilise-reduce\u201d: a survey of the common practices of deprescribing services and recommendations for future services.","volume":"18","author":"Cooper","year":"2023","journal-title":"PLoS One"},{"issue":"1","key":"zcs260001r5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/cap.2024.0099","article-title":"Deprescribing antidepressants in children and adolescents: a systematic review of discontinuation approaches, cross-titration, and withdrawal symptoms.","volume":"35","author":"Stimpfl","year":"2025","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"zcs260001r6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.sleep.2025.01.033","article-title":"Clinical practice guidelines for switching or deprescribing hypnotic medications for chronic insomnia: results of European neuropsychopharmacology and sleep expert\u2019s consensus group.","volume":"128","author":"Palagini","year":"2025","journal-title":"Sleep Med"},{"issue":"4","key":"zcs260001r7","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1093\/schbul\/sbab017","article-title":"A method for tapering antipsychotic treatment that may minimize the risk of relapse.","volume":"47","author":"Horowitz","year":"2021","journal-title":"Schizophr Bull"},{"issue":"2","key":"zcs260001r8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000217","article-title":"Guidance for developers of health research reporting guidelines.","volume":"7","author":"Moher","year":"2010","journal-title":"PLoS Med"},{"issue":"5","key":"zcs260001r10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004390","article-title":"ACcurate COnsensus Reporting Document (ACCORD) explanation and elaboration: guidance and examples to support reporting consensus methods.","volume":"21","author":"Logullo","year":"2024","journal-title":"PLoS Med"},{"issue":"5","key":"zcs260001r11","doi-asserted-by":"publisher","first-page":"384","DOI":"10.4088\/JCP.v63n0502","article-title":"Nonadherence with mood stabilizers: prevalence and predictors.","volume":"63","author":"Scott","year":"2002","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"zcs260001r12","doi-asserted-by":"publisher","first-page":"702","DOI":"10.4088\/JCP.13r08858","article-title":"Nocebo effects in the treatment of major depression: results from an individual study participant-level meta-analysis of the placebo arm of duloxetine clinical trials.","volume":"76","author":"Dodd","year":"2015","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"zcs260001r13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1176\/appi.ajp.20250124","article-title":"A call to psychiatrists: deprescription of unnecessary anticholinergic medications in schizophrenia must start now.","volume":"182","author":"Chengappa","year":"2025","journal-title":"Am J Psychiatry"},{"issue":"9","key":"zcs260001r14","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1001\/jamapsychiatry.2025.1362","article-title":"Incidence and nature of antidepressant discontinuation symptoms: a systematic review and meta-analysis.","volume":"82","author":"Kalfas","year":"2025","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"zcs260001r15","doi-asserted-by":"publisher","first-page":"E202","DOI":"10.1503\/jpn.250054","article-title":"Fluoxetine substitution for deprescribing antidepressants: a technical approach.","volume":"50","author":"Shapiro","year":"2025","journal-title":"J Psychiatry Neurosci"},{"key":"zcs260001r16","first-page":"Doc16","article-title":"50% adherence of patients suffering chronic conditions\u2013where is the evidence?","volume":"10","author":"Mathes","year":"2012","journal-title":"Ger Med Sci"},{"issue":"10","key":"zcs260001r17","doi-asserted-by":"publisher","first-page":"892","DOI":"10.4088\/JCP.v63n1007","article-title":"Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature.","volume":"63","author":"Lacro","year":"2002","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"zcs260001r18","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/wps.20060","article-title":"Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies.","volume":"12","author":"Kane","year":"2013","journal-title":"World Psychiatry"},{"issue":"2","key":"zcs260001r19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.2165\/00019053-200018020-00002","article-title":"Patient compliance with drug therapy in schizophrenia. Economic and clinical issues.","volume":"18","author":"Lindstr\u00f6m","year":"2000","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"zcs260001r20","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/JCP.0000000000000697","article-title":"Accuracy of clinician assessments of medication status in the emergency setting: a comparison of clinician assessment of antipsychotic usage and plasma level determination.","volume":"37","author":"Lopez","year":"2017","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"zcs260001r21","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1037\/0022-006X.70.4.1051","article-title":"Treatment expectancies, patient alliance, and outcome: further analyses from the National Institute of Mental Health Treatment of Depression Collaborative Research Program.","volume":"70","author":"Meyer","year":"2002","journal-title":"J Consult Clin Psychol"},{"issue":"1","key":"zcs260001r22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.psc.2011.11.009","article-title":"How (not what) to prescribe: nonpharmacologic aspects of psychopharmacology.","volume":"35","author":"Mintz","year":"2012","journal-title":"Psychiatr Clin North Am"},{"issue":"10","key":"zcs260001r23","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s40266-013-0106-8","article-title":"Patient barriers to and enablers of deprescribing: a systematic review.","volume":"30","author":"Reeve","year":"2013","journal-title":"Drugs Aging"},{"issue":"2","key":"zcs260001r25","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1521\/pdps.2022.50.2.360","article-title":"Attachment relationships as determinants of physical health.","volume":"50","author":"Maunder","year":"2022","journal-title":"Psychodyn Psychiatry"},{"key":"zcs260001r26","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.psychres.2017.06.050","article-title":"Relationships between patients\u2019 attachment characteristics and views and use of psychiatric treatment.","volume":"256","author":"Adams","year":"2017","journal-title":"Psychiatry Res"},{"issue":"2","key":"zcs260001r27","first-page":"89","article-title":"Transitional objects and transitional phenomena; a study of the first not-me possession.","volume":"34","author":"Winnicott","year":"1953","journal-title":"Int J Psychoanal"},{"issue":"1","key":"zcs260001r29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1176\/appi.ajp.2019.19030228","article-title":"Lithium exposure during pregnancy and the postpartum period: a systematic review and meta-analysis of safety and efficacy outcomes.","volume":"177","author":"Fornaro","year":"2020","journal-title":"Am J Psychiatry"},{"issue":"6","key":"zcs260001r30","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1017\/S1092852924002311","article-title":"Anatomical, behavioral, and cognitive teratogenicity associated with valproic acid: a systematic review.","volume":"29","author":"Valentino","year":"2024","journal-title":"CNS Spectr"},{"issue":"3","key":"zcs260001r32","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.18f12351","article-title":"Valproate in pregnancy: recent research and regulatory responses.","volume":"79","author":"Andrade","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"zcs260001r33","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/jppr2003334323","article-title":"Deprescribing: achieving better health outcomes for older people through reducing medications.","volume":"33","author":"Woodward","year":"2003","journal-title":"J Pharm Pract Res"},{"issue":"6","key":"zcs260001r34","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1017\/S1461145711001192","article-title":"Hyponatraemia during psychopharmacological treatment: results of a drug surveillance programme.","volume":"15","author":"Letmaier","year":"2012","journal-title":"Int J Neuropsychopharmacol"},{"issue":"9","key":"zcs260001r35","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1177\/0706743716659417","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments.","volume":"61","author":"Kennedy","year":"2016","journal-title":"Can J Psychiatry"},{"issue":"16","key":"zcs260001r36","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism.","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"issue":"11","key":"zcs260001r38","article-title":"Pharmacological interventions for people with borderline personality disorder.","volume":"11","author":"Stoffers-Winterling","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"zcs260001r39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.euroneuro.2023.08.502","article-title":"Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment and self-reported side effects in the euthymic phase of bipolar disorders: Results from the FACE-BD cohort.","volume":"77","author":"Vidal","year":"2023","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"zcs260001r40","first-page":"42","article-title":"Advanced practice nursing roles, regulation, education, and practice: a global study.","volume":"88","author":"Wheeler","year":"2022","journal-title":"Ann Glob Health"},{"issue":"6","key":"zcs260001r41","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1001\/archpsyc.1993.01820180046005","article-title":"Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders.","volume":"50","author":"Faedda","year":"1993","journal-title":"Arch Gen Psychiatry"},{"key":"zcs260001r42","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.569912","article-title":"Antipsychotic withdrawal symptoms: a systematic review and meta-analysis.","volume":"11","author":"Brandt","year":"2020","journal-title":"Front Psychiatry"},{"key":"zcs260001r9","volume-title":"RAND Methodological Guidance for Conducting and Critically Appraising Delphi Panels","author":"Khodyakov","year":"2023"},{"key":"zcs260001r24","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9781615379064","volume-title":"Psychodynamic Psychopharmacology: Caring for the Treatment-Resistant Patient","author":"Mintz","year":"2022"},{"key":"zcs260001r28","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195113976.001.0001","volume-title":"The Practice of Autonomy: Patients, Doctors, and Medical Decisions","author":"Schneider","year":"1998"},{"key":"zcs260001r31","unstructured":"Statement on the risks associated with use of valproic acid (sodium valproate) in women and girls of childbearing potential. World Health Organization medical product alert. May 2, 2023. Accessed online August 16, 2025. https:\/\/www.who.int\/news\/item\/02-05-2023-use-of-valproic-acid-in-women-and-girls-of-childbearing-potential"},{"key":"zcs260001r37","unstructured":"United Nations Population Fund. Seeing the unseen: the case for action in the neglected crisis of unintended pregnancy. 2022. Accessed November 29, 2025. https:\/\/www.unfpa.org\/swp2022"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2845497\/goldberg_2026_cs_260001_1772557085.83532.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:30:54Z","timestamp":1772559054000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2845497"}},"subtitle":["A Consensus Statement From the American Society of Clinical Psychopharmacology Task Force"],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.0043","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]}}}